Literature DB >> 25672560

Prognostic and Predictive Value of the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer Patients After Complete Cytoreductive Surgery: Study of Tumor Bank Ovarian Cancer.

Khayal Gasimli1, Elena Ioana Braicu, Rolf Richter, Radoslav Chekerov, Jalid Sehouli.   

Abstract

PURPOSE: The peritoneal cancer index (PCI) is used to refer gastrointestinal malignancy patients to either palliative or curative management of their peritoneal carcinomatosis. The aim of this retrospective study was to evaluate the prognostic value of the PCI in patients with primary advanced epithelial ovarian cancer (EOC) after complete cytoreductive surgery.
METHODS: PCI quantitatively assesses cancer distribution on the peritoneum by calculating tumor sizes in each of 13 abdominopelvic regions. Correlation between PCI score and clinical factors were analyzed using Kendall's tau b. Univariate and multivariate survival analyses were performed with the Kaplan-Meier method and Cox regression model, respectively.
RESULTS: We retrospectively enrolled 80 consecutive patients with primary EOC treated in our gynecology department. All patients underwent complete cytoreductive surgery. Patients whose history included interval tumor debulking and completion cytoreductive surgery were excluded. Most tumors were of a serous histological subtype (96.3 %). Median age at diagnosis was 58.0 years. Their median PCI score was 12.0 (range 3-32). We found statistical correlations between PCI and ascites (p = 0.001), surgery duration (p < 0.001), T status of TNM staging (p = 0.036), and preoperative CA 125 (p = 0.025). In the univariate analysis, higher PCI scores were related to poor overall (OS) and progression-free (PFS) survival rates (p = 0.036 and p < 0.001, respectively). Multivariate analysis showed that the association remained significant only for PFS (p = 0.005), not for OS (p = 0.162).
CONCLUSIONS: PCI did not portend OS in patients with primary ovarian cancer. Further prospective and multicenter studies are needed to validate these results.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25672560     DOI: 10.1245/s10434-014-4329-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  10 in total

1.  Accuracy of CT Scan in Predicting the Surgical PCI in Patients Undergoing Cytoreductive Surgery with/without HIPEC-a Prospective Single Institution Study.

Authors:  Gaurav Goswami; Praveen Kammar; Ramesh Mangal; Sakina Shaikh; Mahesh D Patel; Aditi Bhatt
Journal:  Indian J Surg Oncol       Date:  2019-03-28

2.  Implications of peritoneal cancer index distribution on patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Jolene Si Min Wong; Grace Hwei Ching Tan; Sabrina Hui Xian Cheok; Chin-Ann Johnny Ong; Claramae Shulyn Chia; Melissa Ching Ching Teo
Journal:  Pleura Peritoneum       Date:  2022-04-26

3.  The exosomal integrin α5β1/AEP complex derived from epithelial ovarian cancer cells promotes peritoneal metastasis through regulating mesothelial cell proliferation and migration.

Authors:  Xiaoduan Li; Meiling Tang; Qinyi Zhu; Xinjing Wang; Yingying Lin; Xipeng Wang
Journal:  Cell Oncol (Dordr)       Date:  2020-02-21       Impact factor: 6.730

4.  E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer.

Authors:  Fabian Trillsch; Sascha Kuerti; Christine Eulenburg; Eike Burandt; Linn Woelber; Katharina Prieske; Kathrin Eylmann; Leticia Oliveira-Ferrer; Karin Milde-Langosch; Sven Mahner
Journal:  Br J Cancer       Date:  2016-01-19       Impact factor: 7.640

5.  Effect of tumor burden and radical surgery on survival difference between upfront, early interval or delayed cytoreductive surgery in ovarian cancer.

Authors:  Martina Aida Angeles; Bastien Cabarrou; Antonio Gil-Moreno; Asunción Pérez-Benavente; Emanuela Spagnolo; Agnieszka Rychlik; Carlos Martínez-Gómez; Frédéric Guyon; Ignacio Zapardiel; Denis Querleu; Claire Illac; Federico Migliorelli; Sarah Bétrian; Gwénaël Ferron; Alicia Hernández; Alejandra Martinez
Journal:  J Gynecol Oncol       Date:  2021-08-13       Impact factor: 4.401

6.  Postoperative pulmonary complications and outcomes in cytoreductive surgery for ovarian cancer: a propensity-matched analysis.

Authors:  Mengmeng Xu; Wei Zhang; Chen Gao; Ying Zhou; Yanhu Xie
Journal:  BMC Anesthesiol       Date:  2022-04-23       Impact factor: 2.217

7.  Association between High Diffusion-Weighted Imaging-Derived Functional Tumor Burden of Peritoneal Carcinomatosis and Overall Survival in Patients with Advanced Ovarian Carcinoma.

Authors:  He An; Jose A U Perucho; Keith W H Chiu; Edward S Hui; Mandy M Y Chu; Siew Fei Ngu; Hextan Y S Ngan; Elaine Y P Lee
Journal:  Korean J Radiol       Date:  2022-05       Impact factor: 3.500

8.  Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study.

Authors:  Alaa A Elzarkaa; Waleed Shaalan; Doaa Elemam; Hassan Mansour; Mahmoud Melis; Eduard Malik; Amr A Soliman
Journal:  J Gynecol Oncol       Date:  2018-03-08       Impact factor: 4.401

9.  Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters.

Authors:  Hanna Sartor; Maria Bjurberg; Mihaela Asp; Anna Kahn; Jenny Brändstedt; Päivi Kannisto; Karin Jirström
Journal:  J Ovarian Res       Date:  2020-03-07       Impact factor: 4.234

10.  Role of Laparotomy-based Parameters in Assessment of Optimal Primary Debulking Surgery and Long-term Outcomes in Patients with Stage IIIC Epithelial Ovarian Cancer.

Authors:  Mingyi Zhou; Danbo Wang; Zaiqiu Long; Yong Zhang; Jing Liu
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.